217 related articles for article (PubMed ID: 38019518)
21. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study.
Verberk IMW; Laarhuis MB; van den Bosch KA; Ebenau JL; van Leeuwenstijn M; Prins ND; Scheltens P; Teunissen CE; van der Flier WM
Lancet Healthy Longev; 2021 Feb; 2(2):e87-e95. PubMed ID: 36098162
[TBL] [Abstract][Full Text] [Related]
22. Relationship between topological efficiency of white matter structural connectome and plasma biomarkers across the Alzheimer's disease continuum.
Zhang M; Chen H; Huang W; Guo T; Ma G; Han Y; Shu N
Hum Brain Mapp; 2024 Jan; 45(1):e26566. PubMed ID: 38224535
[TBL] [Abstract][Full Text] [Related]
23. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.
Huang Y; Li Y; Xie F; Guo Q
CNS Neurosci Ther; 2022 Dec; 28(12):2195-2205. PubMed ID: 36074638
[TBL] [Abstract][Full Text] [Related]
24. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
25. Brief Report: Undercarboxylated Osteocalcin Is Associated With Cognition in Women With and Without HIV.
Ross RD; Olali AZ; Shi Q; Hoover DR; Sharma A; Weber KM; French AL; McKay H; Tien PC; Yin MT; Rubin LH
J Acquir Immune Defic Syndr; 2022 Oct; 91(2):162-167. PubMed ID: 36094482
[TBL] [Abstract][Full Text] [Related]
26. Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals.
Brum WS; Ashton NJ; Simrén J; di Molfetta G; Karikari TK; Benedet AL; Zimmer ER; Lantero-Rodriguez J; Montoliu-Gaya L; Jeromin A; Aarsand AK; Bartlett WA; Calle PF; Coşkun A; Díaz-Garzón J; Jonker N; Zetterberg H; Sandberg S; Carobene A; Blennow K
Alzheimers Dement; 2024 Feb; 20(2):1284-1297. PubMed ID: 37985230
[TBL] [Abstract][Full Text] [Related]
27. The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men.
Gillespie NA; Elman JA; McKenzie RE; Tu XM; Xian H; Reynolds CA; Panizzon MS; Lyons MJ; Eglit GML; Neale MC; Rissman RA; Franz C; Kremen WS
Alzheimers Dement; 2024 Jan; 20(1):356-365. PubMed ID: 37622539
[TBL] [Abstract][Full Text] [Related]
28. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
Mattsson-Carlgren N; Salvadó G; Ashton NJ; Tideman P; Stomrud E; Zetterberg H; Ossenkoppele R; Betthauser TJ; Cody KA; Jonaitis EM; Langhough R; Palmqvist S; Blennow K; Janelidze S; Johnson SC; Hansson O
JAMA Neurol; 2023 Apr; 80(4):360-369. PubMed ID: 36745413
[TBL] [Abstract][Full Text] [Related]
29. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort.
Sarto J; Ruiz-García R; Guillén N; Ramos-Campoy Ó; Falgàs N; Esteller D; Contador J; Fernández G; González Y; Tort-Merino A; Juncà-Parella J; Bosch B; Borrego-Écija S; Molina-Porcel L; Castellví M; Vergara M; Antonell A; Augé JM; Naranjo L; Sanchez-Valle R; Lladó A; Balasa M
Neurology; 2023 Feb; 100(8):e860-e873. PubMed ID: 36450604
[TBL] [Abstract][Full Text] [Related]
31. Impact of pre-analytical sample handling factors on plasma biomarkers of Alzheimer's disease.
Kurz C; Stöckl L; Schrurs I; Suridjan I; Gürsel SÜ; Bittner T; Jethwa A; Perneczky R
J Neurochem; 2023 Apr; 165(1):95-105. PubMed ID: 36625424
[TBL] [Abstract][Full Text] [Related]
32. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
[TBL] [Abstract][Full Text] [Related]
33. Comparison of plasma and CSF biomarkers in predicting cognitive decline.
Aschenbrenner AJ; Li Y; Henson RL; Volluz K; Hassenstab J; Verghese P; West T; Meyer MR; Kirmess KM; Fagan AM; Xiong C; Holtzman D; Morris JC; Bateman RJ; Schindler SE
Ann Clin Transl Neurol; 2022 Nov; 9(11):1739-1751. PubMed ID: 36183195
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.
Chatterjee P; Pedrini S; Ashton NJ; Tegg M; Goozee K; Singh AK; Karikari TK; Simrén J; Vanmechelen E; Armstrong NJ; Hone E; Asih PR; Taddei K; Doré V; Villemagne VL; Sohrabi HR; Zetterberg H; Masters CL; Blennow K; Martins RN
Alzheimers Dement; 2022 Jun; 18(6):1141-1154. PubMed ID: 34494715
[TBL] [Abstract][Full Text] [Related]
36. Association of cognitive function with Neurofilament light chain in the aqueous humor of human eye.
Bai J; Wan Z; Wang M; Wu X; Wang T; Zhang Y; Xue Y; Xu H; Peng Q
Front Aging Neurosci; 2022; 14():1027705. PubMed ID: 36408096
[TBL] [Abstract][Full Text] [Related]
37. Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury.
Gonzalez-Ortiz F; Dulewicz M; Ashton NJ; Kac PR; Zetterberg H; Andersson E; Yakoub Y; Hanrieder J; Turton M; Harrison P; Nellgård B; Karikari TK; Blennow K
JAMA Netw Open; 2023 Jul; 6(7):e2321554. PubMed ID: 37399012
[TBL] [Abstract][Full Text] [Related]
38. Preanalytical stability of plasma biomarkers for Alzheimer's disease pathology.
Sunde AL; Alsnes IV; Aarsland D; Ashton NJ; Tovar-Rios DA; De Santis G; Blennow K; Zetterberg H; Kjosavik SR
Alzheimers Dement (Amst); 2023; 15(2):e12439. PubMed ID: 37192842
[TBL] [Abstract][Full Text] [Related]
39. Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study.
Baldacci F; Lista S; Manca ML; Chiesa PA; Cavedo E; Lemercier P; Zetterberg H; Blennow K; Habert MO; Potier MC; Dubois B; Vergallo A; Hampel H; ;
Alzheimers Res Ther; 2020 Nov; 12(1):147. PubMed ID: 33183357
[TBL] [Abstract][Full Text] [Related]
40. The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD).
Yu F; Pituch KA; Maxfield M; Baena E; Geda YE; Pruzin JJ; Coon DW; Shaibi GQ;
PLoS One; 2024; 19(4):e0295749. PubMed ID: 38558059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
